FDA Approves Abaloparatide (Tymlos) for Osteoporosis in Men

The FDA has approved abaloparatide (Tymlos) for increasing bone density in men with osteoporosis at high risk for fracture.
FDA Approvals

source https://www.medscape.com/viewarticle/986014?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?